- Goldman Sachs backs Oracle (ORCL.US): AI financing concerns may be exaggerated; risks of ongoing projects are controllable
- Rosenblatt Securities lowers CoreWeave target price to $160
- TREACE MEDICAL CONCEPTS, INC. <TMCI.O>: STIFEL RAISES TO BUY FROM HOLD; RAISES TARGET PRICE TO $6.5 FROM $4.5
- INSTALLED BUILDING PRODUCTS, INC. <IBP.N>: STIFEL CUTS TO HOLD FROM BUY; RAISES TARGET PRICE TO $225 FROM $220
- PARKIT ENTERPRISE INC : RAYMOND JAMES RAISES TO OUTPERFORM FROM MARKET PERFORM; CUTS TARGET PRICE TO C$8.5 FROM C$9
- BUZZ-Akamai Technologies shares fall after announcing $2.2 billion convertible bond issuance
- DRAFTKINGS INC. <DKNG.O>: STIFEL CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $21 FROM $32
- BUZZ-Akamai Technologies shares fall after announcing $2.2 billion convertible bond offering
- "The Big Short" investor Michael Burry slashed his Caterpillar (CAT.US) position after nearly tripling profits, as valuation pressures may persist amid uncertain growth prospects
- Meta plans to expand its AI age estimation technology to the global Facebook and Threads platforms this year.
- Meta expands AI age estimation technology globally to protect Instagram teen accounts
- VULCAN MATERIALS CO <VMC.N>: STIFEL RAISES TARGET PRICE TO $342 FROM $320
- UFP INDUSTRIES, INC. <UFPI.O>: STIFEL CUTS TARGET PRICE TO $80 FROM $85
- TRUPANION, INC. <TRUP.O>: STIFEL RAISES TARGET PRICE TO $34 FROM $29
- TREX COMPANY, INC. <TREX.N>: STIFEL RAISES TARGET PRICE TO $62 FROM $55
- MSA SAFETY INC <MSA.N>: D.A. DAVIDSON CUTS TARGET PRICE TO $216 FROM $223
- Nextech3D.ai Closes $720,000 Private Placement
- CorMedix, Heron: Transaction Expected Immediately Accretive to CorMedix Earnings, Free Cash Flow, as Well as Estimated to Generate $45M-$60 M in Near-Term Total Operating Cost Synergies >CRMD
- CorMedix, Heron: Transaction to Add 4 Comml-stage Products to CorMedix's Hospital- and Acute-Care-Focused Comml Platform >CRMD
- CorMedix Entered Into New Senior Secured Term Loan Facility With Funds Managed by Pharmakon Advisors, Will Draw $75M of Non-Dilutive Financing to Support Transaction >CRMD
- STARBUCKS <SBUX.O>: STIFEL RESUMES COVERAGE WITH BUY RATING; TARGET PRICE $115
- Rubellite Energy Swings to Q3 Net Loss of CAD 27.13 Million
- Rubellite Energy management commentary cites unrealized hedging losses as main driver of Q3 2026 net loss
- BOX INC <BOX.N>: D.A. DAVIDSON RAISES TARGET PRICE TO $60 FROM $50
- DUTCH BROS INC. <BROS.N>: STIFEL RESUMES COVERAGE WITH BUY RATING; TARGET PRICE $48
- CorMedix, Heron: Additional Consideration to Total Up to $55M in Earn-Out Payments to Heron Tied to 2028 ZYNRELEF Net Sales, Plus Royalty on Net Sales of Certain Products Above Sales Threshold >CRMD
- CorMedix, Heron: Upfront Consideration to Consist of $145M in Cash, Plus 14.6M CorMedix Shrs >CRMD HRTX
- Fact II Acquisition Seeks Shareholder Approval to Extend Business Combination Deadline to November 25, 2027
- Compugen presents immuno-oncology pipeline update, targets COM701 interim analysis in Q1 2027
- WASGAU Q1-Q3 2026 EBIT Falls 23% to EUR 5.66 Million
- BLACK ROCK COFFEE BAR, INC. <BRCB.O>: STIFEL RESUMES COVERAGE WITH HOLD RATING; TARGET PRICE $12
- Voyageurs du Monde Reports 4,488,763 Shares Outstanding as of Oct. 31
- PEFINDO affirms Eagle High Plantations bonds at idA-
- IRHYTHM HOLDINGS, INC <IRTC.O>: TRUIST SECURITIES CUTS TARGET PRICE TO $140.00 FROM $168.00
- CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care >CRMD HRTX
- WESTLAKE CORP <WLK.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $81.00 FROM $90.00
- Electra Battery Materials Swings to Three-Month Net Profit of CAD 4.64 Million
- VERICEL CORPORATION <VCEL.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $65.00 FROM $52.00
- União Pet Buys Back 2,800,800 Shares for R$ 11.08 Million
- VEEVA SYSTEMS INC. <VEEV.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $360.00 FROM $305.00
- Immunovant: FDA Discussions Planned for Later This Yr to Determine the Path Forward Regarding the Registrational Program for IMVT-1402 in D2T RA >IMVT
- Immunovant: In Light of Evolving Sjögren's Disease Landscape and Recent Data in the Field, Expect It Is Unlikely That We Will Advance IMVT-1402 Further in SjD Beyond the Ongoing, Fully Enrolled Phase 2 Trial >IMVT
- Immunovant: All Other Clinical Development Timelines Remain on Track >IMVT
- Acsion Appoints Matsela Sethebe as Non-Executive Director
- Autolus Therapeutics to Participate in Jefferies Global Healthcare Conference
- aap Implantate supervisory board member’s close associate Jürgen Krebs receives 272,495 subscription rights for EUR 0
- Immunovant 2Q Loss/Shr 47c >IMVT
- Roivant Sciences 2Q Loss/Shr 27c >ROIV
- Roivant Sciences 2Q Rev $35.1M >ROIV
- EEX expands carbon market offering with EU ETS2 auction and spot contracts from January 2027
- TG Therapeutics 3Q Rev $259.9M >TGTX
- Rubellite Energy 3Q Loss/Shr C$0.29 >RBY.T
- TG Therapeutics Raises 2026 View To Rev $1B >TGTX
- Village Farms Intl: Closes 3Q With $80M in Cash and Net Cash Position of $41M >VFF
- Rubellite Energy 3Q Rev C$81.7M >RBY.T
- Merval, closely associated with aap Implantate supervisory board member Nathalie Krebs, receives 1,249,640 subscription rights for EUR 0
- NeurAxis Q3 2026 net loss more than triples year over year to $6.55 million
- LDC takes minority stake in LEDA Orthopaedics
- Chosa Oncology Expects First US Platin-DRP Test Revenue in Summer 2027, Pending Validation
- EVERQUOTE, INC. <EVER.O>: RAYMOND JAMES RAISES TARGET PRICE TO $32 FROM $28
- Walker & Dunlop Presents Multifamily Financing Growth Opportunities in Investor Overview
- Foghorn Therapeutics swings to Q3 2026 net income of $58.2 million
- Village Farms Intl 3Q EPS 8c >VFF
- Village Farms Intl 3Q Sales $66.9M >VFF
- APA CORPORATION : TRUIST SECURITIES RAISES TARGET PRICE TO $50.00 FROM $45.00
- Viking Therapeutics Announces Two VK2735 Poster Presentations at ObesityWeek
- Superior Group of Companies Q3 net income falls 6% to $2.57 million
- UBIQUITI, INC. <UI.N>: BARCLAYS RAISES TARGET PRICE TO $537 FROM $489
- AMN HEALTHCARE SERVICES, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $45.00 FROM $40.00
- TRIMBLE INC. <TRMB.O>: BARCLAYS CUTS TARGET PRICE TO $78 FROM $80
- SEADRILL LIMITED <SDRL.N>: BARCLAYS RAISES TARGET PRICE TO $61 FROM $59
- PRIMO BRANDS CORPORATION : BARCLAYS RAISES TARGET PRICE TO $29 FROM $26
- NABORS INDUSTRIES <NBR.N>: BARCLAYS CUTS TARGET PRICE TO $85 FROM $93
- MP MATERIALS CORP. <MP.N>: BARCLAYS CUTS TARGET PRICE TO $54 FROM $65
- MOLSON COORS BEVERAGE COMPANY <TAP.N>: BARCLAYS RAISES TARGET PRICE TO $40 FROM $36
- Praxis Precision Med 3Q Loss/Shr $3.23 >PRAX
- Praxis Precision Med 3Q Research and Development Expenses $64.2M >PRAX
- Aura Biosciences: Expected Cash Runway Into 1st Half of 2029 >AURA
- Aura Biosciences 3Q Loss $32.1M >AURA
- Aura Biosciences 3Q Loss/Shr 29c >AURA
- Virtus Invst Partners 3Q EPS $3.26 >VRTS
- Virtus Invst Partners 3Q Adj EPS $5.86 >VRTS
- Virtus Invst Partners 3Q Net $19.4M >VRTS
- Virtus Invst Partners 3Q Rev $197.6M >VRTS
- JPMorgan Downgrades Molson Coors Beverage to Underweight From Neutral, $37 Price Target
- TD Cowen Downgrades Pan American Silver to Hold From Buy, CA$63.46 Price Target
- Stifel Nicolaus Downgrades Installed Building Products to Hold From Buy, $225 Price Target
- Top Premarket Gainers
- AbbVie Unit Says GLP-1 Patients Report Improved Satisfaction With Facial Appearance in 2 Studies
- --Earnings Flash (TNGX) Tango Therapeutics Posts Q3 Loss $0.39 a Share, vs. FactSet Est of $0.35 Loss
- Roivant Sciences' Fiscal Q2 Net Loss Widens, Revenue Increases
- Update: Orix Fiscal Q2 Earnings, Revenue Rise
- NRG Selling 6 Natural Gas Generation Assets to LS Power for $4 Billion
- TG Therapeutics' Q3 Earnings Decline, Revenue Increases; 2026 Revenue Outlook Raised
- --Earnings Flash (KSPI) Kaspi.kz Posts Q3 revenue of 1.10T Kazakhstani Tenge, vs. FactSet Est. of 1.21T Tenge
- --Earnings Flash (KSPI) Kaspi.kz Posts Q3 Net Income 281B Kazakhstani Tenge, vs. FactSet Est of 285.35B Tenge
- Constellation Energy Q3 Adjusted Operating Earnings, Revenue Rise; 2026 Adjusted EPS Raised - Shares Up Pre-Bell
- Praxis Precision Medicines Q3 Loss Narrows
- Maxus Mining to Raise up to CA$1.25 Million Via Non-Brokered Private Placement
- NRG Energy's Q3 Adjusted Earnings, Revenue Rise
